Can-Fite BioPharma Ltd.
CANF · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,454 | $6,454 | $4,825 | $4,825 |
| Short-Term Investments | $2 | $2 | $3,062 | $3,062 |
| Receivables | $0 | $0 | $77 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,168 | $1,168 | $1,018 | $1,095 |
| Total Curr. Assets | $7,624 | $7,624 | $8,982 | $8,982 |
| Property Plant & Equip (Net) | $96 | $96 | $138 | $138 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $96 | $96 | $138 | $138 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,720 | $7,720 | $9,120 | $9,120 |
| Liabilities | – | – | – | – |
| Payables | $1,152 | $1,152 | $618 | $618 |
| Short-Term Debt | $57 | $57 | $106 | $53 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $405 | $0 | $405 | $0 |
| Other Curr. Liab. | $506 | $911 | $923 | $1,381 |
| Total Curr. Liab. | $2,120 | $2,120 | $2,052 | $2,052 |
| LT Debt | $33 | $33 | $51 | $51 |
| Deferred Rev, NC | $1,383 | $0 | $1,581 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1,383 | $0 | $1,581 |
| Total NC Liab. | $1,416 | $1,416 | $1,632 | $1,632 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $90 | $90 | $104 | $104 |
| Total Liabilities | $3,536 | $3,536 | $3,684 | $3,684 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$171,237 | -$171,237 | -$166,361 | -$166,361 |
| AOCI | $1,127 | $1,127 | $1,127 | $1,127 |
| Other Equity | $174,294 | $174,294 | $170,670 | $170,670 |
| Total Equity | $4,184 | $4,184 | $5,436 | $5,436 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,720 | $7,720 | $9,120 | $9,120 |
| Net Debt | -$6,364 | -$6,364 | -$4,668 | -$4,721 |